Financial Ratios Alignment Healthcare, Inc.

Equities

ALHC

US01625V1044

Managed Healthcare

Market Closed - Nasdaq Other stock markets 21:00:00 10/12/2025 GMT			5-day change	1st Jan Change
18.91 ^USD	-1.56%		-0.99%	+68.09%

11-13	Alignment Healthcare Insider Sold Shares Worth $2,936,772, According to a Recent SEC Filing	MT
10-31	UBS Adjusts Alignment Healthcare Price Target to $18 From $17, Maintains Neutral Rating	MT

300b5f5419ae976d2d424f5ec2.WSkhU8wqIksjZEYuA2_tDRi7uxanKME-K9PG3XD3fw8.OG5wN_1ffSNxKXMYZAuiSnzp73vtSolkRZiXkyfaSVkGUEYbv2UXf3AIcg

Published financial data: ALIGNMENT HEALTHCARE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Premiums and Annuity Revenues	955M	1.17B	1.43B	1.8B	2.67B
Other Revenues, Total	3.83M	688K	2.61M	22.7M	31.63M
Total Revenues	959M	1.17B	1.43B	1.82B	2.7B
Policy Benefits	793M	1.04B	1.25B	1.62B	2.41B
Depreciation & Amortization - (IS) - (Collected)	15.1M	15.81M	17.27M	21.41M	26.27M
Selling General & Admin Expenses, Total	156M	291M	296M	306M	369M
Total Operating Expenses	964M	1.35B	1.56B	1.95B	2.8B
Operating Income	-5.26M	-178M	-129M	-126M	-98.48M
Interest Expense, Total	-16.93M	-17.44M	-18.29M	-21.23M	-23.55M
Other Non Operating Income (Expenses)	274K	229K	-75K	564K	206K
EBT, Excl. Unusual Items	-21.92M	-195M	-147M	-147M	-122M
Restructuring Charges	-	-	-	-	-1.57M
Gain (Loss) on Sale of Assets	-1.01M	-	-101K	289K	9K
Asset Writedown	-	-	-	-	-743K
Legal Settlements	-	-	-	-1.9M	-913K
Other Unusual Items	-	-	-2.2M	-	-3.02M
EBT, Incl. Unusual Items	-22.93M	-195M	-149M	-148M	-128M
Income Tax Expense	-	-	339K	-22K	21K
Earnings From Continuing Operations	-22.93M	-195M	-150M	-148M	-128M
Net Income to Company	-22.93M	-195M	-150M	-148M	-128M
Minority Interest	-	-	92K	156K	36K
Net Income - (IS)	-22.93M	-195M	-150M	-148M	-128M
Net Income to Common Incl Extra Items	-22.93M	-195M	-150M	-148M	-128M
Net Income to Common Excl. Extra Items	-22.93M	-195M	-150M	-148M	-128M
Per Share Items
Net EPS - Basic	-36.92	-1.14	-0.83	-0.79	-0.67
Basic EPS - Continuing Operations	-36.92	-1.14	-0.83	-0.79	-0.67
Basic Weighted Average Shares Outstanding	621K	172M	181M	186M	191M
Net EPS - Diluted	-36.92	-1.14	-0.83	-0.79	-0.67
Diluted EPS - Continuing Operations	-36.92	-1.14	-0.83	-0.79	-0.67
Diluted Weighted Average Shares Outstanding	621K	172M	181M	186M	191M
Normalized Basic EPS	-22.06	-0.71	-0.51	-0.49	-0.4
Normalized Diluted EPS	-22.06	-0.71	-0.51	-0.49	-0.4
Supplemental Items
EBITDA	10.2M	-162M	-111M	-104M	-71.41M
EBITA	-4.94M	-178M	-128M	-126M	-97.77M
EBIT	-5.26M	-178M	-129M	-126M	-98.48M
EBITDAR	13.87M	-158M	-108M	-102M	-68.62M
Total Revenues (As Reported)	959M	1.17B	1.43B	1.82B	2.7B
Effective Tax Rate - (Ratio)	-	-	-0.23	0.01	-0.02
Normalized Net Income	-13.7M	-122M	-91.78M	-91.46M	-76.1M
Interest on Long-Term Debt	16.93M	17.44M	18.29M	21.23M	23.55M
Supplemental Operating Expense Items
Advertising Expense	-	3.58M	7.96M	6.96M	5.76M
Selling and Marketing Expenses	-	3.58M	7.96M	6.96M	5.76M
Net Rental Expense, Total	3.67M	3.6M	3.37M	2.68M	2.79M
Imputed Operating Lease Interest Expense	3.36M	3.15M	2.99M	2.67M	2.09M
Imputed Operating Lease Depreciation	308K	452K	383K	12.66K	700K
Stock-Based Comp., SG&A Exp. (Total)	2.12M	107M	72.59M	59.29M	66.2M
Stock-Based Comp., Other (Total)	-	15.42M	9.13M	7.54M	4.93M
Total Stock-Based Compensation	2.12M	122M	81.72M	66.84M	71.13M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Total Other Investments	-	-	-	116M	37.79M
Total investments	-	-	-	116M	37.79M
Cash And Equivalents	207M	467M	410M	203M	433M
Other Receivables - (Insurance Template)	40.14M	58.51M	92.89M	120M	154M
Gross Property Plant And Equipment	110M	126M	148M	186M	224M
Accumulated Depreciation	-72.71M	-88.2M	-105M	-124M	-149M
Net Property Plant And Equipment	37.03M	38.21M	42.99M	61.86M	74.96M
Goodwill	29.3M	29.3M	34.81M	34.83M	34.83M
Other Intangibles, Total	5.34M	5.81M	5.48M	5.25M	4.55M
Other Current Assets, Total	17.22M	27.75M	42.11M	44.97M	37.08M
Other Long-Term Assets, Total	2.15M	4.71M	6.04M	6.4M	6.09M
Total Assets	339M	631M	634M	592M	782M
Liabilities
Accounts Payable, Total	12.32M	13.72M	28.09M	20.88M	20M
Accrued Expenses, Total	138M	150M	198M	240M	330M
Current Portion of Leases	3.35M	3.71M	4.2M	1.72M	1.21M
Long-Term Debt	144M	151M	161M	162M	321M
Long-Term Leases	10.27M	6.98M	3.7M	8.97M	7.84M
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	-	-	-	913K	913K
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	308M	325M	395M	434M	681M
Common Stock, Total	-	188K	187K	189K	192K
Additional Paid In Capital	-	881M	970M	1.04B	1.11B
Retained Earnings	30.61M	-575M	-732M	-880M	-1.01B
Total Common Equity	30.61M	306M	238M	157M	99.85M
Minority Interest	-	15K	1.18M	1.12M	1.1M
Total Equity	30.61M	306M	239M	158M	101M
Total Liabilities And Equity	339M	631M	634M	592M	782M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	621K	187M	187M	189M	192M
ECS Total Common Shares Outstanding	621K	187M	187M	189M	192M
Book Value / Share	49.3	1.63	1.27	0.83	0.52
Tangible Book Value	-4.03M	271M	198M	117M	60.48M
Tangible Book Value Per Share	-6.5	1.45	1.06	0.62	0.32
Total Debt	158M	161M	169M	173M	330M
Net Debt	-49.52M	-305M	-241M	-30.4M	-102M
Debt Equivalent Oper. Leases	29.36M	28.82M	26.99M	21.46M	22.32M
Minority Interest, Total (Incl. Fin. Div)	-	15K	1.18M	1.12M	1.1M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	12.67M	13.58M	15.44M	15.84M	16.91M
Full Time Employees	775	847	1.04K	1.54K	1.68K

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-22.93M	-195M	-150M	-148M	-128M
Depreciation, Depletion & Amortization	15.13M	15.67M	17.1M	21.44M	26.36M
Amortization of Goodwill and Intangible Assets - (CF)	327K	362K	386K	226K	702K
Total Depreciation, Depletion & Amortization	15.46M	16.03M	17.49M	21.67M	27.06M
Amortization of Deferred Charges, Total	2.19M	2.25M	1.85M	-	1.29M
(Gain) Loss On Sale of Asset - (CF)	1.01M	-	611K	-	-9K
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-2.58M
Total Asset Writedown	-	-	-	-289K	143K
Stock-Based Compensation (CF)	2.12M	111M	81.72M	66.84M	71.13M
Provision and Write-off of Bad Debts	118K	111K	150K	91K	123K
Change in Accounts Receivable	-4.63M	-17.61M	-34.38M	-26.95M	-34.28M
Change in Accounts Payable	645K	437K	13.74M	-6.35M	-1.46M
Change in Other Net Operating Assets (Collected)	7.24M	-2.24M	15.08M	35.32M	96.63M
Other Operating Activities	6.33M	6.93M	7.86M	-1.5M	4.75M
Cash from Operations	7.56M	-78.78M	-45.43M	-59.19M	34.77M
Capital Expenditure	-15.71M	-19.76M	-23.77M	-36M	-41.42M
Sale of Property, Plant, and Equipment	100K	-	-	-	14K
Cash Acquisitions	-	-	-4.04M	-	-
Investment in Marketable and Equity Securities, Total	-750K	-1.05M	-400K	-111M	80.6M
Cash from Investing	-16.36M	-20.82M	-28.22M	-147M	39.19M
Long-Term Debt Issued, Total	-	-	165M	-	380M
Total Debt Issued	-	-	165M	-	380M
Long-Term Debt Repaid, Total	-	-	-143M	-	-215M
Total Debt Repaid	-	-	-143M	-	-215M
Issuance of Common Stock	135M	391M	-	-	155K
Repurchase of Common Stock	-1.5M	-1.47M	-	-	-350K
Other Financing Activities, Total	-3.37M	-29M	-5.23M	105K	-8.78M
Cash from Financing	130M	360M	16.59M	105K	156M
Net Change in Cash	121M	261M	-57.05M	-206M	230M
Supplemental Items
Cash Interest Paid	10.72M	10.99M	22.45M	19.16M	22.16M
Net Debt Issued / Repaid	-	-	21.82M	-	165M
Levered Free Cash Flow	-6.45M	-17.13M	-1.07M	-150M	123M
Unlevered Free Cash Flow	1.94M	-8.48M	8.51M	-136M	136M
Change In Net Working Capital	-3.35M	15.46M	-13.48M	110M	-141M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-1.24	-22.96	-12.71	-12.84	-8.96
Return on Total Capital	-2.66	-33.94	-18.37	-21.31	-16.15
Return On Equity %	95.33	-116.01	-54.88	-74.58	-98.89
Return on Common Equity	95.33	-116.02	-54.96	-74.93	-99.72
Margin Analysis
Gross Profit Margin %	17.33	11.02	12.85	11.02	10.97
SG&A Margin	16.3	24.92	20.61	16.75	13.64
EBITDA Margin %	1.06	-13.88	-7.75	-5.72	-2.64
EBITA Margin %	-0.51	-15.22	-8.94	-6.89	-3.62
EBIT Margin %	-0.55	-15.25	-8.97	-6.9	-3.64
Income From Continuing Operations Margin %	-2.39	-16.72	-10.43	-8.13	-4.74
Net Income Margin %	-2.39	-16.72	-10.43	-8.12	-4.74
Net Avail. For Common Margin %	-2.39	-16.72	-10.43	-8.12	-4.74
Normalized Net Income Margin	-1.43	-10.45	-6.4	-5.02	-2.81
Levered Free Cash Flow Margin	-0.67	-1.47	-0.07	-8.2	4.55
Unlevered Free Cash Flow Margin	0.2	-0.73	0.59	-7.47	5.05
Asset Turnover
Asset Turnover	3.61	2.41	2.27	2.98	3.94
Fixed Assets Turnover	29.75	31.04	35.32	34.78	39.52
Short Term Liquidity
Current Ratio	1.72	3.31	2.37	1.84	1.88
Quick Ratio	1.61	3.14	2.18	1.67	1.78
Operating Cash Flow to Current Liabilities	0.05	-0.47	-0.2	-0.23	0.1
Average Days Payable Outstanding	6.39	4.58	6.1	5.51	3.18
Long Term Solvency
Total Debt/Equity	515.47	52.7	70.54	109.13	327.35
Total Debt / Total Capital	83.75	34.51	41.36	52.18	76.6
LT Debt/Equity	504.52	51.49	68.78	108.04	326.15
Long-Term Debt / Total Capital	81.97	33.72	40.33	51.66	76.32
Total Liabilities / Total Assets	90.96	51.49	62.25	73.29	87.09
EBIT / Interest Expense	-0.31	-10.21	-7.03	-5.93	-4.18
EBITDA / Interest Expense	0.82	-9.08	-5.89	-4.78	-2.91
(EBITDA - Capex) / Interest Expense	-0.11	-10.22	-7.19	-6.48	-4.67
Total Debt / EBITDA	11.38	-1.02	-1.57	-1.7	-4.82
Net Debt / EBITDA	-3.57	1.93	2.23	0.3	1.49
Total Debt / (EBITDA - Capex)	-85.76	-0.91	-1.28	-1.25	-3
Net Debt / (EBITDA - Capex)	26.91	1.71	1.83	0.22	0.93
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	26.72	21.74	22.81	27.16	48.25
Gross Profit, 1 Yr. Growth %	73.93	-22.56	43.15	9.09	47.59
EBITDA, 1 Yr. Growth %	-179.05	-1.69K	-31.4	-6.21	-32.72
EBITA, 1 Yr. Growth %	-83.07	3.5K	-27.83	-2	-23.37
EBIT, 1 Yr. Growth %	-82.15	3.28K	-27.76	-2.12	-22.96
Earnings From Cont. Operations, 1 Yr. Growth %	-48.75	751.81	-23.37	-0.98	-13.57
Net Income, 1 Yr. Growth %	-48.75	751.81	-23.42	-1.02	-13.5
Normalized Net Income, 1 Yr. Growth %	-50.53	790.9	-24.8	-0.01	-17.86
Diluted EPS Before Extra, 1 Yr. Growth %	-53.27	653.61	-27.33	-3.68	-15.58
Net Property, Plant and Equip., 1 Yr. Growth %	34.95	3.18	12.52	43.88	21.17
Total Assets, 1 Yr. Growth %	74.99	86.38	0.47	-6.62	32.13
Common Equity, 1 Yr. Growth %	-138.89	899.77	-22.19	-34.09	-36.38
Tangible Book Value, 1 Yr. Growth %	-96.45	-6.82K	-26.98	-40.93	-48.25
Cash From Operations, 1 Yr. Growth %	-17.89	-1.14K	-42.33	30.29	-158.75
Capital Expenditures, 1 Yr. Growth %	53.32	25.83	20.28	51.4	15.07
Levered Free Cash Flow, 1 Yr. Growth %	-	165.44	-93.77	5.03K	-182.28
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-538.31	-200.34	-1.7K	-199.23
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	24.21	22.28	24.97	37.3
Gross Profit, 2 Yr. CAGR %	-	16.06	5.29	24.96	26.89
EBITDA, 2 Yr. CAGR %	-	254.4	230.14	-19.79	-19.85
EBITA, 2 Yr. CAGR %	-	146.88	409.74	-15.9	-12.69
EBIT, 2 Yr. CAGR %	-	145.76	394.39	-15.91	-12.51
Earnings From Cont. Operations, 2 Yr. CAGR %	-	108.94	155.48	-12.89	-7.49
Net Income, 2 Yr. CAGR %	-	108.94	155.4	-12.94	-7.47
Normalized Net Income, 2 Yr. CAGR %	-	109.93	158.84	-13.44	-8.79
Diluted EPS Before Extra, 2 Yr. CAGR %	-	85.72	134.01	-16.34	-9.82
Net Property, Plant and Equip., 2 Yr. CAGR %	-	18	7.75	27.24	32.04
Total Assets, 2 Yr. CAGR %	-	80.59	36.84	-3.14	11.08
Common Equity, 2 Yr. CAGR %	-	97.18	178.91	-28.39	-35.25
Tangible Book Value, 2 Yr. CAGR %	-	54.38	600.3	-34.32	-44.71
Cash From Operations, 2 Yr. CAGR %	-	192.49	145.11	-13.32	-12.51
Capital Expenditures, 2 Yr. CAGR %	-	38.9	23.02	34.95	31.99
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-59.32	177.75	973.11
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	109.71	300.79	300.31
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	23.74	23.88	32.29
Gross Profit, 3 Yr. CAGR %	-	-	24.47	6.54	32.09
EBITDA, 3 Yr. CAGR %	-	-	105.01	117.03	-23.9
EBITA, 3 Yr. CAGR %	-	-	63.85	194.2	-18.06
EBIT, 3 Yr. CAGR %	-	-	63.4	188.15	-17.92
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	49.56	86.27	-13.12
Net Income, 3 Yr. CAGR %	-	-	49.53	86.21	-13.13
Normalized Net Income, 3 Yr. CAGR %	-	-	49.09	88.29	-14.57
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	35.84	74.07	-16.09
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	16.14	18.65	25.18
Total Assets, 3 Yr. CAGR %	-	-	48.53	20.47	7.42
Common Equity, 3 Yr. CAGR %	-	-	44.63	72.43	-31.16
Tangible Book Value, 3 Yr. CAGR %	-	-	20.28	207.13	-39.34
Cash From Operations, 3 Yr. CAGR %	-	-	70.24	98.56	-23.86
Capital Expenditures, 3 Yr. CAGR %	-	-	32.39	31.84	27.97
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	185.09	85.12
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	312.92	152.4
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	28.99
Gross Profit, 5 Yr. CAGR %	-	-	-	-	25.43
EBITDA, 5 Yr. CAGR %	-	-	-	-	40.81
EBITA, 5 Yr. CAGR %	-	-	-	-	27.38
EBIT, 5 Yr. CAGR %	-	-	-	-	27.28
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	23.41
Net Income, 5 Yr. CAGR %	-	-	-	-	23.41
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	22.4
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	15.31
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	22.26
Total Assets, 5 Yr. CAGR %	-	-	-	-	32.23
Common Equity, 5 Yr. CAGR %	-	-	-	-	4.87
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	-11.86
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	30.44
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	32.23